A few years ago, I started paying attention to the word "microbiome." It appeared in wellness blogs, supplement advertisements, kombucha labels, and eventually in conversations with my doctor. Everyone, it seemed, had an opinion about gut bacteria. Probiotics were the new multivitamin. Fermented foods were the new superfoods. And the microbiome — that enormous colony of trillions of microorganisms living inside each of us — was the new frontier of medicine.
Some of this enthusiasm is warranted. The last two decades of microbiome research have produced genuinely astonishing discoveries that could fundamentally reshape our understanding of human health. But the gap between what science has established and what the wellness industry is selling remains enormous — and navigating that gap requires understanding what the research actually says.
What lives inside you
The human microbiome comprises an estimated 38 trillion microorganisms — roughly the same number as human cells in your body (Sender et al., 2016). The majority reside in the large intestine, where they form an ecosystem of extraordinary complexity. A single gram of colonic content contains more individual organisms than there are people on earth.
This is not, as it was once thought, a collection of passive hitchhikers. The gut microbiome is metabolically active on a scale that rivals the liver. It synthesizes vitamins, metabolizes dietary compounds that human enzymes cannot break down, trains the immune system, maintains the integrity of the intestinal barrier, and produces neurotransmitters — including roughly 95% of the body's serotonin (Yano et al., 2015).
The composition of your microbiome is unique to you — as individual as a fingerprint — and is shaped by a complex interplay of factors including birth method, breastfeeding, geography, diet, antibiotic exposure, stress, sleep, and physical activity. Twin studies have demonstrated that genetics play a surprisingly modest role, accounting for only about 5-10% of microbiome variation (Rothschild et al., 2018). Your microbiome is largely a product of your environment and your choices.
The gut-brain axis
Perhaps the most fascinating — and most overhyped — area of microbiome research involves the bidirectional communication system between the gut and the brain, known as the gut-brain axis. This is not metaphor. The gut contains its own nervous system — the enteric nervous system — comprising roughly 500 million neurons, and it communicates with the central nervous system through the vagus nerve, immune signaling molecules, and microbially produced metabolites.
A landmark study published in Nature Microbiology analyzed gut microbiome data from over 1,000 participants enrolled in the Flemish Gut Flora Project and identified specific bacterial taxa that were consistently depleted in individuals with depression, even after controlling for antidepressant use (Valles-Colomer et al., 2019). The bacteria Coprococcus and Dialister were significantly reduced in depressed individuals, and these same organisms are known to produce butyrate — a short-chain fatty acid with anti-inflammatory properties and neuroactive potential.
This does not mean that gut bacteria cause depression. The relationship is almost certainly bidirectional: depression alters gut function, and altered gut function may worsen depression. But the finding that specific microbial signatures correlate with psychiatric conditions across large populations has opened an entirely new line of investigation for mental health treatment.
Animal studies have been even more provocative. Germ-free mice — raised in sterile environments with no microbiome at all — exhibit dramatically altered behavior: increased anxiety, impaired social interaction, and exaggerated stress responses. When colonized with microbiomes from depressed humans, these mice develop depressive-like behaviors. When colonized with microbiomes from healthy humans, they do not (Zheng et al., 2016). These are striking findings, though translating rodent microbiome research to human clinical practice has proven enormously difficult.
The immune connection
If the gut-brain axis has captured public imagination, the relationship between the microbiome and the immune system may be even more clinically consequential. Approximately 70% of the body's immune cells reside in the gut-associated lymphoid tissue, and the microbiome plays a critical role in educating and calibrating the immune response throughout life.
The "hygiene hypothesis" — now more accurately termed the "old friends hypothesis" — proposes that the dramatic rise in autoimmune and allergic diseases over the past century is partly attributable to reduced microbial diversity. As societies industrialized, urbanized, and adopted modern sanitation, antibiotic use, and processed diets, exposure to the diverse microorganisms that co-evolved with humans diminished substantially. The immune system, deprived of the microbial signals it evolved to expect, may default to inflammatory patterns that attack the body's own tissues or overreact to harmless environmental triggers.
This is supported by epidemiological data showing that autoimmune disease prevalence is inversely correlated with microbial exposure. Children raised on farms have significantly lower rates of asthma and allergies than urban children (Stein et al., 2016). Countries with higher antibiotic consumption have higher rates of inflammatory bowel disease. And a meta-analysis published in the BMJ found that antibiotic exposure in the first two years of life was associated with increased risk of childhood asthma, eczema, and food allergies (Ahmadizar et al., 2018).
What the science does not yet support
This is where intellectual honesty becomes essential, because the commercial microbiome industry has raced far ahead of the evidence. Let me be specific about what current research does not support:
Most commercial probiotics have limited evidence for healthy individuals. A systematic review published in the Annals of Internal Medicine evaluated 45 randomized controlled trials of probiotics in healthy adults and found no consistent evidence of lasting microbiome modification, immune enhancement, or metabolic benefit (Kristensen et al., 2016). Probiotics have demonstrated efficacy for specific, narrow conditions — antibiotic-associated diarrhea, certain forms of irritable bowel syndrome, prevention of necrotizing enterocolitis in premature infants — but the generalized claim that probiotics "improve gut health" in otherwise healthy people is not well supported.
Microbiome testing for personalized health recommendations is premature. Companies offering at-home stool testing with personalized dietary recommendations based on microbiome composition are marketing a service that current science cannot reliably deliver. A study published in Cell demonstrated that even the most sophisticated microbiome profiling explained only about 17% of individual variation in blood glucose response to foods — suggesting that microbiome-based dietary recommendations are, at best, modestly informative and, at worst, misleading (Berry et al., 2020).
Fecal microbiota transplantation (FMT) is effective for one condition. FMT has demonstrated remarkable efficacy for recurrent Clostridioides difficile infection, with cure rates exceeding 90%. But trials for other conditions — inflammatory bowel disease, metabolic syndrome, autism spectrum disorder — have produced mixed and largely disappointing results. FMT remains an experimental procedure for all indications other than C. difficile, and carries genuine safety risks including the potential transmission of antibiotic-resistant organisms (DeFilipp et al., 2019).
What you can actually do
Given the enormous complexity of microbiome science and the limitations of current interventions, the most evidence-based approach to supporting a healthy microbiome is reassuringly simple — and aligns closely with general dietary recommendations:
Dietary fiber diversity is the single most important modifiable factor. The microbiome is sustained by dietary fiber — specifically, the diverse array of complex carbohydrates found in whole grains, legumes, fruits, vegetables, nuts, and seeds that human enzymes cannot digest. Different bacterial species specialize in fermenting different fiber types, so dietary diversity directly supports microbial diversity. A study in Cell Host & Microbe demonstrated that a high-fiber diet increased microbial diversity and reduced inflammatory markers within just two weeks (Wastyk et al., 2021). The researchers recommended consuming 30 or more distinct plant foods per week — not as exotic as it sounds when you count herbs, spices, nuts, seeds, grains, and vegetables individually.
Fermented foods have emerging evidence. A randomized controlled trial from Stanford University compared high-fiber and high-fermented-food diets over 10 weeks. Both improved health markers, but the high-fermented-food diet produced the more striking result: a significant reduction in 19 inflammatory markers and an increase in microbial diversity that persisted after the intervention ended (Wastyk et al., 2021). Foods like yogurt, kefir, kimchi, sauerkraut, miso, and kombucha appear to introduce metabolically active organisms and their byproducts in a way that supplements may not replicate.
Minimize unnecessary antibiotic exposure. Antibiotics are life-saving medications when appropriately prescribed. But their impact on the microbiome is severe and potentially long-lasting. A single course of broad-spectrum antibiotics can reduce microbial diversity by 25% or more, and some species may not recover for months — or at all (Palleja et al., 2018). The clinical implication is not to avoid antibiotics when they are needed, but to resist demanding them for viral infections where they provide no benefit.
The microbiome revolution is real. But like most genuine scientific revolutions, it will unfold over decades, not product cycles. The most important thing you can do right now is eat a diverse diet rich in fiber and fermented foods, avoid unnecessary antibiotics, and maintain a healthy skepticism toward anyone claiming to decode your microbiome for a subscription fee.
References
- Ahmadizar, F., et al. (2018). Early-life antibiotic exposure increases the risk of developing allergic symptoms. Allergy, 73(5), 971–986.
- Berry, S. E., et al. (2020). Human postprandial responses to food and potential for precision nutrition. Nature Medicine, 26(6), 964–973.
- DeFilipp, Z., et al. (2019). Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. NEJM, 381(21), 2043–2050.
- Kristensen, N. B., et al. (2016). Alterations in fecal microbiota composition by probiotic supplementation in healthy adults. Annals of Internal Medicine, 165(1), 42–49.
- Palleja, A., et al. (2018). Recovery of gut microbiota of healthy adults following antibiotic exposure. Nature Microbiology, 3(11), 1255–1265.
- Rothschild, D., et al. (2018). Environment dominates over host genetics in shaping human gut microbiota. Nature, 555(7695), 210–215.
- Sender, R., et al. (2016). Revised estimates for the number of human and bacteria cells in the body. Cell, 164(3), 337–340.
- Stein, M. M., et al. (2016). Innate immunity and asthma risk in Amish and Hutterite farm children. NEJM, 375(5), 411–421.
- Valles-Colomer, M., et al. (2019). The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology, 4(4), 623–632.
- Wastyk, H. C., et al. (2021). Gut-microbiota-targeted diets modulate human immune status. Cell, 184(16), 4137–4153.
- Yano, J. M., et al. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 161(2), 264–276.
- Zheng, P., et al. (2016). Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Molecular Psychiatry, 21(6), 786–796.